Advanced Enzyme

41
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
305.90
-8.1 (-2.58%)
BSENSE

Dec 05

BSE+NSE Vol: 1.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
636.00
623.00
540.00
529.00
501.00
443.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
636.00
623.00
540.00
529.00
501.00
443.00
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
-10.00
4.00
-20.00
-1.00
-9.00
Raw Materials Consumed
161.00
155.00
127.00
130.00
100.00
90.00
Power & Fuel Cost
38.00
41.00
38.00
29.00
21.00
19.00
Employee Cost
141.00
127.00
114.00
103.00
87.00
80.00
Operating Expenses
32.00
32.00
26.00
22.00
16.00
15.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
24.00
17.00
17.00
16.00
9.00
10.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
13.00
12.00
15.00
8.00
7.00
6.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
441.00
418.00
383.00
326.00
269.00
240.00
Operating Profit (PBDIT) excl Other Income
195.00
205.00
157.00
202.00
232.00
203.00
Other Income
33.00
36.00
25.00
6.00
8.00
5.00
Operating Profit (PBDIT)
228.00
242.00
182.00
208.00
241.00
209.00
Interest
4.00
4.00
3.00
2.00
2.00
4.00
Profit before Depriciation and Tax
223.00
238.00
179.00
206.00
238.00
204.00
Depreciation
36.00
35.00
35.00
34.00
28.00
25.00
Profit Before Taxation & Exceptional Items
187.00
202.00
144.00
171.00
210.00
179.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
187.00
187.00
140.00
171.00
210.00
179.00
Provision for Tax
53.00
50.00
36.00
47.00
58.00
46.00
Profit After Tax
133.00
136.00
103.00
123.00
151.00
133.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,079.00
1,002.00
907.00
797.00
657.00
537.00
Profit Available for appropriations
1,210.00
1,135.00
1,012.00
917.00
803.00
666.00
Appropriations
1,210.00
1,135.00
1,012.00
917.00
803.00
666.00
Equity Dividend (%)
260.00%
255.00%
50.00%
50.00%
45.00%
30.00%
Earnings Per Share
11.72
11.92
9.45
10.70
13.06
11.58
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.09% vs 15.39% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -4.93% vs 30.57% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 12.42% vs 18.49% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -2.17% vs 31.85% in Mar 2024

Compare Profit and Loss Results of Advanced Enzyme
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
636.00
819.00
-183.00
-22.34%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
636.00
819.00
-183.00
-22.34%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
-24.00
14.00
58.33%
Raw Materials Consumed
161.00
399.00
-238.00
-59.65%
Power & Fuel Cost
38.00
18.00
20.00
111.11%
Employee Cost
141.00
127.00
14.00
11.02%
Operating Expenses
32.00
29.00
3.00
10.34%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
47.00
-23.00
-48.94%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
13.00
11.00
2.00
18.18%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
441.00
683.00
-242.00
-35.43%
Operating Profit (PBDIT) excl Other Income
195.00
136.00
59.00
43.38%
Other Income
33.00
3.00
30.00
1,000.00%
Operating Profit (PBDIT)
228.00
139.00
89.00
64.03%
Interest
4.00
24.00
-20.00
-83.33%
Profit before Depriciation and Tax
223.00
115.00
108.00
93.91%
Depreciation
36.00
21.00
15.00
71.43%
Profit Before Taxation & Exceptional Items
187.00
94.00
93.00
98.94%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
187.00
94.00
93.00
98.94%
Provision for Tax
53.00
24.00
29.00
120.83%
Profit After Tax
133.00
69.00
64.00
92.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,079.00
352.00
727.00
206.53%
Profit Available for appropriations
1,210.00
422.00
788.00
186.73%
Appropriations
1,210.00
422.00
788.00
186.73%
Equity Dividend (%)
260%
10%
250.00
Earnings Per Share
11.72
6.95
4.77
68.63%
Profit And Loss - Net Sales
Net Sales 636.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.09% vs 15.39% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 195.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -4.93% vs 30.57% in Mar 2024

Profit And Loss - Interest
Interest 4.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.42% vs 18.49% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 133.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.17% vs 31.85% in Mar 2024